Vascular Graft Solutions (VGS), established in 2009, focuses on improving coronary revascularization procedures through innovative technologies. Operating in the medical device industry, VGS primarily serves cardiac surgeons and healthcare providers involved in coronary artery bypass grafting (CABG). The company aims to enhance both short and long-term outcomes of CABG, a widely performed cardiac surgery, by providing external support for vein grafts. VGS's business model revolves around the development, clinical validation, and commercialization of its patented devices, which are FDA cleared and CE marked for sale in various regions including the US, Europe, Australia, Israel, and Mexico. Revenue is generated through the sale of these medical devices to hospitals and healthcare facilities. VGS's mission is to advance the standard of care in coronary bypass surgery, focusing on improving patient quality of life and reducing the economic burden on healthcare systems.

Keywords: coronary revascularization, CABG, medical devices, vein graft support, FDA cleared, CE marked, cardiac surgery, healthcare innovation, clinical validation, patented technologies.